Anticoagulation and Neuraxial/Peripheral Anesthesia

Mudit Kaushal; Ryan E. Rubin; Alan D. Kaye; Karina Gritsenko

doi:10.1016/j.anclin.2017.01.002

Anticoagulation and Neuraxial/Peripheral Anesthesia

Mudit Kaushal, Ryan E. Rubin, Alan D. Kaye, Karina Gritsenko

Anesthesiology

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Abstract

Novel anticoagulants (NAGs) have emerged as the preferred alternatives to vitamin K antagonists. In patients being considered for regional anesthesia, these drugs present a layer of complexity in the preprocedure evaluation. There are no established tests to monitor anticoagulant activity and our experience is short with these drugs. These authors believe it is important to review the relevant hematology, orthopedics, and anesthesiology literature to provide a valuable reference for the clinician who is met with these challenges. In addition to discussing NAGs, we also review the existing American Society of Regional Anesthesia guidelines for heparin, low-molecular-weight heparin, and antiplatelet agents.

Original language	English (US)
Pages (from-to)	e21-e39
Journal	Anesthesiology Clinics
Volume	35
Issue number	2
DOIs	https://doi.org/10.1016/j.anclin.2017.01.002
State	Published - Jun 1 2017

Keywords

Anticoagulation
Antiplatelet
Coumadin
Direct thrombin inhibitors
Factor Xa inhibitors
Neuraxial
Regional

ASJC Scopus subject areas

Anesthesiology and Pain Medicine

Access to Document

10.1016/j.anclin.2017.01.002

Cite this

@article{ee726be733ea45449e2152603ae4fd1f,

title = "Anticoagulation and Neuraxial/Peripheral Anesthesia",

abstract = "Novel anticoagulants (NAGs) have emerged as the preferred alternatives to vitamin K antagonists. In patients being considered for regional anesthesia, these drugs present a layer of complexity in the preprocedure evaluation. There are no established tests to monitor anticoagulant activity and our experience is short with these drugs. These authors believe it is important to review the relevant hematology, orthopedics, and anesthesiology literature to provide a valuable reference for the clinician who is met with these challenges. In addition to discussing NAGs, we also review the existing American Society of Regional Anesthesia guidelines for heparin, low-molecular-weight heparin, and antiplatelet agents.",

keywords = "Anticoagulation, Antiplatelet, Coumadin, Direct thrombin inhibitors, Factor Xa inhibitors, Neuraxial, Regional",

author = "Mudit Kaushal and Rubin, {Ryan E.} and Kaye, {Alan D.} and Karina Gritsenko",

year = "2017",

month = jun,

day = "1",

doi = "10.1016/j.anclin.2017.01.002",

language = "English (US)",

volume = "35",

pages = "e21--e39",

journal = "Anesthesiology Clinics",

issn = "1932-2275",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Anticoagulation and Neuraxial/Peripheral Anesthesia

AU - Kaushal, Mudit

AU - Rubin, Ryan E.

AU - Kaye, Alan D.

AU - Gritsenko, Karina

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Novel anticoagulants (NAGs) have emerged as the preferred alternatives to vitamin K antagonists. In patients being considered for regional anesthesia, these drugs present a layer of complexity in the preprocedure evaluation. There are no established tests to monitor anticoagulant activity and our experience is short with these drugs. These authors believe it is important to review the relevant hematology, orthopedics, and anesthesiology literature to provide a valuable reference for the clinician who is met with these challenges. In addition to discussing NAGs, we also review the existing American Society of Regional Anesthesia guidelines for heparin, low-molecular-weight heparin, and antiplatelet agents.

AB - Novel anticoagulants (NAGs) have emerged as the preferred alternatives to vitamin K antagonists. In patients being considered for regional anesthesia, these drugs present a layer of complexity in the preprocedure evaluation. There are no established tests to monitor anticoagulant activity and our experience is short with these drugs. These authors believe it is important to review the relevant hematology, orthopedics, and anesthesiology literature to provide a valuable reference for the clinician who is met with these challenges. In addition to discussing NAGs, we also review the existing American Society of Regional Anesthesia guidelines for heparin, low-molecular-weight heparin, and antiplatelet agents.

KW - Anticoagulation

KW - Antiplatelet

KW - Coumadin

KW - Direct thrombin inhibitors

KW - Factor Xa inhibitors

KW - Neuraxial

KW - Regional

UR - http://www.scopus.com/inward/record.url?scp=85019639466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019639466&partnerID=8YFLogxK

U2 - 10.1016/j.anclin.2017.01.002

DO - 10.1016/j.anclin.2017.01.002

M3 - Review article

C2 - 28526159

AN - SCOPUS:85019639466

SN - 1932-2275

VL - 35

SP - e21-e39

JO - Anesthesiology Clinics

JF - Anesthesiology Clinics

IS - 2

ER -

Anticoagulation and Neuraxial/Peripheral Anesthesia

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this